Cargando…

Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development

Antisense oligonucleotides (ASOs) are an increasingly represented class of drugs. These small sequences of nucleotides are designed to precisely target other oligonucleotides, usually RNA species, and are modified to protect them from degradation by nucleases. Their specificity is due to their seque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quemener, Anais M., Centomo, Maria Laura, Sax, Scott L., Panella, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781596/ https://www.ncbi.nlm.nih.gov/pubmed/35056851 http://dx.doi.org/10.3390/molecules27020536

Ejemplares similares

Antisense oligonucleotide: A promising therapeutic option to beat COVID‐19
por: Quemener, Anaïs M., et al.
Publicado: (2021)

The powerful world of antisense oligonucleotides: From bench to bedside
por: Quemener, Anaïs M., et al.
Publicado: (2020)

Drug Discovery Perspectives of Antisense Oligonucleotides
por: Kim, Yeonjoon
Publicado: (2023)

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
por: Dhuri, Karishma, et al.
Publicado: (2020)

Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
por: Gagliardi, Maria, et al.
Publicado: (2021)

Managing the sequence-specificity of antisense oligonucleotides in drug discovery
por: Hagedorn, Peter H., et al.
Publicado: (2017)

Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
por: Gareri, Clarice, et al.
Publicado: (2022)

Respirable antisense oligonucleotides: a new drug class for respiratory disease
por: Tanaka, Makoto, et al.
Publicado: (2001)

Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs
por: Takakusa, Hideo, et al.
Publicado: (2023)

Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
por: Wada, Fumito, et al.
Publicado: (2021)

Huge familial colloid cyst of the third ventricle: An extraordinary presentation
por: Niknejad, Hamid Reza, et al.
Publicado: (2015)

Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS
por: Kandasamy, Pachamuthu, et al.
Publicado: (2022)

Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018)

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)

Antisense Oligonucleotides and RNA Interference
por: Kher, Gitanjali, et al.
Publicado: (2011)

Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol
por: Kavallaris, M, et al.
Publicado: (1999)

GalNAc Conjugation Attenuates the Cytotoxicity of Antisense Oligonucleotide Drugs in Renal Tubular Cells
por: Sewing, Sabine, et al.
Publicado: (2018)

Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs
por: Laikova, Kateryna V., et al.
Publicado: (2019)

In vivo uptake of antisense oligonucleotide drugs predicted by ab initio quantum mechanical calculations
por: Hansen, Henrik Frydenlund, et al.
Publicado: (2021)

Improved targeting of miRNA with antisense oligonucleotides
por: Davis, Scott, et al.
Publicado: (2006)

Opportunities and challenges for antisense oligonucleotide therapies
por: Kuijper, Elsa C., et al.
Publicado: (2020)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
por: Jani, Saumya, et al.
Publicado: (2021)

In-silico study of antisense oligonucleotide antibiotics
por: Chen, Erica S., et al.
Publicado: (2023)

Morpholino antisense oligonucleotides: tools for investigating vertebrate development
por: Corey, David R, et al.
Publicado: (2001)

Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides
por: Aung-Htut, May T., et al.
Publicado: (2019)

Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension
por: Yasuhara, Hidenori, et al.
Publicado: (2022)

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021)

An Antisense Oligonucleotide Drug Targeting miR-21 Induces H1650 Apoptosis and Caspase Activation
por: Ge, Jian-Hua, et al.
Publicado: (2019)

Development of Antisense Drugs for Dyslipidemia
por: Yamamoto, Tsuyoshi, et al.
Publicado: (2016)

The choice of negative control antisense oligonucleotides dramatically impacts downstream analysis depending on the cellular background
por: Ducoli, Luca, et al.
Publicado: (2021)

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849 + 10 kb C-to-T splicing mutation
por: Oren, Yifat S., et al.
Publicado: (2021)

Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development
por: Pavlova, Nikolet, et al.
Publicado: (2023)

Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol
por: Nishina, Tomoko, et al.
Publicado: (2015)

Antisense Oligonucleotide-Mediated Transcript Knockdown in Zebrafish
por: Pauli, Andrea, et al.
Publicado: (2015)

Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides
por: Goyenvalle, Aurelie, et al.
Publicado: (2016)

Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
por: Sardone, Valentina, et al.
Publicado: (2017)

The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases
por: Ulanova, Marina, et al.
Publicado: (2012)

Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement
por: Batista-Duharte, Alexander, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nplcrpt7djcvf80e9pphbcg5a1